CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: beta-muricholic acid
Accession: CHEBI:81298
browse the term
Definition: A member of the class of muricholic acids in which the hydroxy groups at positions 6 and 7 both have beta configuration.
Synonyms: related_synonym: (3alpha,5beta,6beta,7beta)-3,6,7-trihydroxycholan-24-oic acid; 3,6,7-trihydroxy-5beta-cholan-24-oic acid; 3alpha,6beta,7beta-Trihydroxy-5beta-cholan-24-oic acid; 5beta-Cholanic acid-3alpha,6beta,7beta-triol; Formula=C24H40O5; InChI=1S/C24H40O5/c1-13(4-7-19(26)27)15-5-6-16-20-17(9-11-23(15,16)2)24(3)10-8-14(25)12-18(24)21(28)22(20)29/h13-18,20-22,25,28-29H,4-12H2,1-3H3,(H,26,27)/t13-,14-,15-,16+,17+,18+,20+,21+,22-,23-,24-/m1/s1; InChIKey=DKPMWHFRUGMUKF-CRKPLTDNSA-N; SMILES=C1[C@H](C[C@@]2([C@](C1)([C@@]3([C@@]([C@H]([C@H]2O)O)([C@@]4([H])[C@@](CC3)(C)[C@](CC4)([C@@H](CCC(O)=O)C)[H])[H])[H])C)[H])O; beta-MCA
xref: CAS:2393-59-1; KEGG:C17726; LIPID_MAPS_instance:LMST04010067; MetaCyc:CPD-16583; PMID:12401895; PMID:1519265; PMID:1568576; PMID:16413764; PMID:20671298; PMID:2815149; PMID:3828364; PMID:3834660; PMID:4210666; PMID:4462033; PMID:6047622; PMID:8245721; Reaxys:3221234
cyclic_relationship: is_conjugate_acid_of CHEBI:134119
G
Abcb11
ATP binding cassette subfamily B member 11
increases expression multiple interactions
EXP
tauromuricholic acid results in increased expression of ABCB11 protein tauromuricholic acid results in increased expression of and results in increased activity of ABCB11 protein
CTD
PMID:11672435 PMID:12644037
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression multiple interactions
EXP
tauromuricholic acid results in increased expression of ABCC2 protein tauromuricholic acid results in increased expression of and results in increased activity of ABCC2 protein
CTD
PMID:11672435 PMID:12644037
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression
EXP
tauromuricholic acid results in increased expression of ABCC3 protein
CTD
PMID:11672435
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Ahr
aryl hydrocarbon receptor
multiple interactions increases abundance increases secretion
ISO
AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin affects the secretion of tauromuricholic acid] AHR gene mutant form results in increased abundance of tauromuricholic acid AHR gene mutant form results in increased secretion of tauromuricholic acid
CTD
PMID:29452137 PMID:32679164
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[Taurocholic Acid co-treated with muricholic acid co-treated with tauromuricholic acid] results in increased expression of CXCL2 mRNA
CTD
PMID:22098667
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[Taurocholic Acid co-treated with muricholic acid co-treated with tauromuricholic acid] results in increased expression of CXCL1 mRNA
CTD
PMID:22098667
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Fech
ferrochelatase
affects abundance
ISO
FECH protein affects the abundance of tauromuricholic acid
CTD
PMID:29906468
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Taurocholic Acid co-treated with muricholic acid co-treated with tauromuricholic acid] results in increased expression of ICAM1 mRNA
CTD
PMID:22098667
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
increases abundance
ISO
IL10 gene mutant form results in increased abundance of tauromuricholic acid
CTD
PMID:27580383
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
affects abundance
ISO
NR1H4 protein affects the abundance of tauromuricholic acid
CTD
PMID:30556042
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions increases abundance
ISO
[PPARA gene mutant form results in increased susceptibility to Clofibrate] which results in increased abundance of tauromuricholic acid; PPARA gene mutant form inhibits the reaction [Gemfibrozil results in increased abundance of tauromuricholic acid] PPARA gene mutant form results in increased abundance of tauromuricholic acid
CTD
PMID:24385052 PMID:29175453
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Slc10a2
solute carrier family 10 member 2
increases expression
EXP
tauromuricholic acid results in increased expression of SLC10A2 protein
CTD
PMID:11672435
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Smad3
SMAD family member 3
increases abundance
ISO
SMAD3 protein results in increased abundance of tauromuricholic acid
CTD
PMID:23034213
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all